Blog
RSS FeedPosted by Michael Wonder on 09 Mar 2019
Dutch join backlash at expensive drugs by making their own
8 March 2019 - In a radiation-proof room at the Erasmus Medical Center in Rotterdam, Emar Thomasa sits behind shielded glass ...
Posted by Michael Wonder on 05 Mar 2019
Determining the comparative value of pharmaceutical risk-sharing policies in non–small cell lung cancer using real-world data
2 March 2019 - Risk-sharing arrangements can be used to mitigate uncertainty about the value of a drug by sharing the ...
Posted by Michael Wonder on 07 Feb 2019
Pharma lashes out at the Netherlands over drug pricing policies
6 November 2019 - As the Dutch government gets more aggressive about controlling the cost of medicines, the pharmaceutical industry ...
Posted by Michael Wonder on 06 Feb 2019
Novartis and Vertex battle the Netherlands government over pricing
4 February 2019 - Two large drug makers are squaring off against the Netherlands as drug pricing increasingly becomes a ...
Posted by Michael Wonder on 05 Feb 2019
Big pharma firms criticise Dutch campaign to slash drug prices
5 February 2019 - Foreign pharmaceuticals companies in the Netherlands say they are ‘concerned’ that the government is undermining the ...
Posted by Michael Wonder on 10 Jan 2019
Minister to ‘talk to Novartis’ after five-fold cancer drug price hike
10 January 2019 - Health minister Bruno Bruins is planning to talk to Swiss pharmaceuticals giant Novartis this week about ...
Posted by Michael Wonder on 11 Dec 2018
Better together when buying medicines? Taking stock of the BeNeLuxA initiative
11 December 2018 - With Ireland being the latest to join in June 2018, there is clearly interest in the ...
Posted by Michael Wonder on 20 Sep 2018
Health insurer takes pharma giant to court for ‘evergreening’
20 September 2018 - Health insurance group Menzis is taking legal action against Astra Zeneca, accusing the pharmaceuticals firm of ...
Posted by Michael Wonder on 03 Sep 2018
Dutch doctors fight pharma company’s 500 fold drug price rise
3 September 2018 - Regulator urged to probe Leadiant Biosciences’ alleged abuse of market power. ...
Posted by Michael Wonder on 21 Mar 2018
Using real world data in health technology assessment (HTA) practice: a comparative study of five HTA agencies
21 March 2018 - This study examines whether real world data is incorporated in health technology assessment (HTA) of melanoma drugs ...
Posted by Michael Wonder on 19 Feb 2018
Drug companies are blackmailing us with expensive drugs: health care chief
19 February 2018 - The Dutch healthcare institute Zorginstituut Nederland says insurers should stop paying for expensive drugs if pharmaceutical ...
Posted by Michael Wonder on 19 Oct 2017
Cystic fibrosis patients may take state to court over medicine funding
18 October 2017 - A lobby group for people suffering from cystic fibrosis is considering taking legal action against the ...
Posted by Michael Wonder on 24 Apr 2017
Managed entry agreements for oncology drugs: lessons from the European experience to inform the future
4 April 2017 - The aim of this study was to conduct an analysis on the regulation and application of ...